Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Mayank Mamtani is an analyst at B. Riley Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/14/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/04/2024 | CYTK | Buy Now | Cytokinetics | $54.30 | 69.43% | $122 → $92 | Maintains | Buy | Get Alert |
| 05/24/2024 | GRTS | Buy Now | Gritstone Bio | $0.78 | 285.95% | $6 → $3 | Reiterates | Buy → Buy | Get Alert |
| 05/23/2024 | NVAX | Buy Now | Novavax | $14.27 | 103.22% | $11 → $29 | Maintains | Buy | Get Alert |
| 05/10/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $279.50 | -28.44% | $270 → $200 | Maintains | Neutral | Get Alert |
| 03/28/2024 | CGTX | Buy Now | Cognition Therapeutics | $2.26 | 121.24% | → $5 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2024 | ALT | Buy Now | Altimmune | $6.16 | 224.68% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 03/15/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $279.50 | -3.4% | $155 → $270 | Upgrade | Sell → Neutral | Get Alert |
| 02/27/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $279.50 | -44.54% | $204 → $155 | Downgrade | Neutral → Sell | Get Alert |
| 02/26/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $279.50 | -44.54% | → $155 | Downgrade | Neutral → Sell | Get Alert |
| 02/13/2024 | ALT | Buy Now | Altimmune | $6.16 | 224.68% | → $20 | Maintains | Buy | Get Alert |
| 02/13/2024 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $29 → $32.5 | Downgrade | Buy → Neutral | Get Alert |
| 02/05/2024 | TGTX | Buy Now | TG Therapeutics | $16.45 | 76.29% | $24 → $29 | Maintains | Buy | Get Alert |
| 01/31/2024 | VXRT | Buy Now | Vaxart | $0.63 | 217.51% | → $2 | Upgrade | Neutral → Buy | Get Alert |
| 12/20/2023 | CKPT | Buy Now | Checkpoint Therapeutics | $2.19 | 82.65% | $8 → $4 | Maintains | Buy | Get Alert |
| 11/22/2023 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | $7 → $3.5 | Maintains | Buy | Get Alert |
| 11/09/2023 | ALT | Buy Now | Altimmune | $6.16 | 29.87% | $15 → $8 | Maintains | Buy | Get Alert |
| 11/07/2023 | CYTK | Buy Now | Cytokinetics | $54.30 | 21.55% | → $66 | Initiates | → Buy | Get Alert |
| 10/20/2023 | TGTX | Buy Now | TG Therapeutics | $16.45 | 45.9% | $32 → $24 | Maintains | Buy | Get Alert |
| 10/13/2023 | SCLX | Buy Now | Scilex Holding | $1.65 | 142.42% | → $4 | Initiates | → Buy | Get Alert |
| 09/27/2023 | ICPT | Buy Now | Intercept Pharma | — | — | $15 → $19 | Downgrade | Buy → Neutral | Get Alert |
| 09/11/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $279.50 | -19.86% | → $224 | Reiterates | Neutral → Neutral | Get Alert |
| 09/08/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $16 → $22 | Maintains | Buy | Get Alert |
| 09/06/2023 | DNLI | Buy Now | Denali Therapeutics | $20.73 | 83.31% | → $38 | Initiates | → Buy | Get Alert |
| 09/05/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $279.50 | -19.86% | → $224 | Reiterates | Neutral → Neutral | Get Alert |
| 08/11/2023 | ALT | Buy Now | Altimmune | $6.16 | 143.51% | $20 → $15 | Maintains | Buy | Get Alert |
| 08/09/2023 | NVAX | Buy Now | Novavax | $14.27 | 5.12% | → $15 | Upgrade | Neutral → Buy | Get Alert |
| 08/02/2023 | TGTX | Buy Now | TG Therapeutics | $16.45 | 94.53% | $42 → $32 | Maintains | Buy | Get Alert |
| 08/01/2023 | TGTX | Buy Now | TG Therapeutics | $16.45 | 94.53% | $42 → $32 | Reiterates | Buy → Buy | Get Alert |
| 07/31/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $8 → $16 | Maintains | Buy | Get Alert |
| 07/20/2023 | ARWR | Buy Now | Arrowhead Pharma | $25.84 | 112.85% | → $55 | Reiterates | Buy → Buy | Get Alert |
